Streptomycin inhibits protein synthesis in pathogenic bacteria.
The given statement is True
Streptomycin is in the aminoglycoside class of medication. It works by blocking the ability of 30S ribosomal subunits to make proteins which results in bacterial death and inhibits protein synthesis in pathogenic bacteria
Couldn't generate an explanation.
Generated by AI. May contain inaccuracies — always verify with your textbook.